31 March 2014Kate Alzapiedi

Copyright compliance in the life sciences industry

Now that the rapid exchange of scientific research and product information across international borders has become commonplace, rights holders and users of published material face an increasingly complex set of issues involving reuse rights, permissions, restrictions and fees.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Abbott IP chief: ‘Firms without AI policies scare me’

5 March 2026 The healthcare company’s chief IP counsel is researching how law firms and patent attorneys are using AI tools to inform its own guidelines for external legal providers.

Americas

Moderna inks billion-dollar deal to settle long-running Spikevax dispute

5 March 2026 Moderna settles, agreeing to part with up to $2.25 billion to avoid a trial and secure a licence to continue using the platform underpinning its COVID-19 vaccine.

Careers

DWT recruits first-chair trial litigator as latest hire in IP expansion

4 March 2026 As the firm expands its IP offering, “an unusually versatile lawyer” with chemical, biologics, and medical device spaces expertise joins the New York office.

More features

To cite or not to cite: How can we avoid misuse of AI in court?

Emotional Perception: What next for patent holders?

Nine-partner litigation team leaves Winston & Strawn

Firm adds seven-lawyer team in second major merger

Rooted in rights: Lessons from plant patent infringement and invalidity cases

Final call: Who are the world’s best in-house counsel?

How AI will be shaped by legal and regulatory developments in 2026

Bird & Bird targets Nordic life sciences growth with regulatory hire

Copyright compliance in the life sciences industry

More on this story

Editor's picks

Editor's picks

More features